期刊文献+

Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis 被引量:3

Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis
下载PDF
导出
摘要 AIM: To evaluate long-term prognosis following cyclosporine treatment by examining the rate of surgery avoidance among cyclosporine responders.METHODS: We retrospectively reviewed clinical records for 29 patients diagnosed with severe steroid-refractory ulcerative colitis in our hospital from August 1997 to August 2008 and treated with cyclosporine by continuous intravenous infusion.All patients were treated with intravenous corticosteroids for more than 5 d prior to cyclosporine therapy.Administration was continued for up to 21 d under serum monitoring to maintain cyclosporine levels between 400 and 600 ng/mL.Clinical activity was assessed before and after cyclosporine therapy using the clinical activity index score,with a reduction of ≥ 5 considered to indicate a response.Among responders,we defined cases not requiring surgery for more than 5 years as exhibiting long-term efficacy of cyclosporine.Factors considered to be possibly predictive of long-term efficacy of cyclosporine were sex,age,disease duration,clinical activity index score,C-reactive protein level,hemoglobin level,disease extent,endoscopic findings,and clinical course.RESULTS: Cyclosporine was not discontinued due to side effects in any patient.Nineteen(65.5%) of 29 patients were considered responders.A statistically significant(P = 0.004) inverseas sociation wa s observed between an endoscopic finding of "mucosal bleeding" and responsive cases.Fifteen(9 males,6 females) of these 19 patients were followed for 5 years or more,of whom 9(60%) exhibited long-termefficacy of cyclosporine.Of the 10 non-responders,9(90%) underwent surgery within 6 mo of cyclosporine therapy.None of the following factors had a significant impact on the long-term efficacy of cyclosporine: sex,age,duration of disease,clinical activity index score,C-reactive protein level,hemoglobin level,extent of disease,endoscopic findings,or clinical course.In contrast,a significant association was observed for maintenance therapy with azathioprine after cyclosporine therapy(P = 0.0014).CONCLUSION: Maintenance therapy with azathioprine might improve the long-term efficacy of continuously infused cyclosporine for severe steroid-refractory ulcerative colitis patients. AIM: To evaluate long-term prognosis following cyclosporine treatment by examining the rate of surgery avoidance among cyclosporine responders.METHODS: We retrospectively reviewed clinical records for 29 patients diagnosed with severe steroid-refractory ulcerative colitis in our hospital from August 1997 to August 2008 and treated with cyclosporine by continuous intravenous infusion.All patients were treated with intravenous corticosteroids for more than 5 d prior to cyclosporine therapy.Administration was continued for up to 21 d under serum monitoring to maintain cyclosporine levels between 400 and 600 ng/mL.Clinical activity was assessed before and after cyclosporine therapy using the clinical activity index score,with a reduction of ≥ 5 considered to indicate a response.Among responders,we defined cases not requiring surgery for more than 5 years as exhibiting long-term efficacy of cyclosporine.Factors considered to be possibly predictive of long-term efficacy of cyclosporine were sex,age,disease duration,clinical activity index score,C-reactive protein level,hemoglobin level,disease extent,endoscopic findings,and clinical course.RESULTS: Cyclosporine was not discontinued due to side effects in any patient.Nineteen(65.5%) of 29 patients were considered responders.A statistically significant(P = 0.004) inverseas sociation wa s observed between an endoscopic finding of 'mucosal bleeding' and responsive cases.Fifteen(9 males,6 females) of these 19 patients were followed for 5 years or more,of whom 9(60%) exhibited long-termefficacy of cyclosporine.Of the 10 non-responders,9(90%) underwent surgery within 6 mo of cyclosporine therapy.None of the following factors had a significant impact on the long-term efficacy of cyclosporine: sex,age,duration of disease,clinical activity index score,C-reactive protein level,hemoglobin level,extent of disease,endoscopic findings,or clinical course.In contrast,a significant association was observed for maintenance therapy with azathioprine after cyclosporine therapy(P = 0.0014).CONCLUSION: Maintenance therapy with azathioprine might improve the long-term efficacy of continuously infused cyclosporine for severe steroid-refractory ulcerative colitis patients.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第1期254-261,共8页 世界胃肠病学杂志(英文版)
关键词 ULCERATIVE COLITIS CYCLOSPORINE Maintenance therap Ulcerative colitis Cyclosporine Maintenance therap
  • 相关文献

参考文献20

  • 1Shun‐ichi Maisawa,Mika Sasaki,Shinobu Ida,Keiichi Uchida,Seiichi Kagimoto,Toshiaki Shimizu,Atsushi Yoden.Characteristics of inflammatory bowel disease with an onset before eight years of age: A multicenter epidemiological survey in J apan[J]. J Gastroenterol Hepatol . 2013 (3)
  • 2Cristina López-Martín,María Chaparro,Laura Espinosa,Alicia Bejerano,José Maté,Javier P. Gisbert.Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease[J]. Gastroenterologia y Hepatologia . 2011 (6)
  • 3Taku Kobayashi,Makoto Naganuma,Susumu Okamoto,Tadakazu Hisamatsu,Nagamu Inoue,Hitoshi Ichikawa,Tetsuro Takayama,Riko Saito,Tomohisa Sujino,Haruhiko Ogata,Yasushi Iwao,Toshifumi Hibi.Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis[J]. Journal of Gastroenterology . 2010 (11)
  • 4Murat Toruner,Edward V. Loftus,W. Scott Harmsen,Alan R. Zinsmeister,Robert Orenstein,William J. Sandborn,Jean–Frederic Colombel,Laurence J. Egan.Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease[J].Gastroenterology.2008(4)
  • 5Dan Turner,Catharine M. Walsh,A. Hillary Steinhart,Anne M. Griffiths.<ce:link locator="fx1"/> Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression[J]. Clinical Gastroenterology and Hepatology . 2007 (1)
  • 6David N. Moskovitz,Gert Van Assche,Benedikte Maenhout,Joris Arts,Marc Ferrante,Severine Vermeire,Paul Rutgeerts.Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis[J]. Clinical Gastroenterology and Hepatology . 2006 (6)
  • 7Simon Campbell,Simon Travis,Derek Jewell.Ciclosporin use in acute ulcerative colitis: a long-term experience[J]. European Journal of Gastroenterology & Hepatology . 2005 (1)
  • 8A. G.Fraser,T. R.Orchard,E. M.Robinson,D. P.Jewell.Long‐term risk of malignancy after treatment of inflammatory bowel disease with azathioprine[J]. Alimentary Pharmacology & Therapeutics . 2002 (7)
  • 9Stack,Long,Hawkey.Short‐ and long‐term outcome of patients treated with cyclosporin for severe acute ulcerative colitis[J]. Alimentary Pharmacology & Therapeutics . 2001 (10)
  • 10Geert D’Haens,Liesbeth Lemmens,Karel Geboes,Lieven Vandeputte,Frank Van Acker,Luc Mortelmans,Marc Peeters,Severin Vermeire,Freddy Penninckx,Frederik Nevens,Martin Hiele,Paul Rutgeerts.Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis[J]. Gastroenterology . 2001 (6)

共引文献6

同被引文献36

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部